Transcode Therapeutics Inc (RNAZ)

Oct 14, 2025

TransCode Therapeutics Advances Cancer Treatment After Successful Phase 1a Trial of TTX-MC138 - citybuzz

Oct 14, 2025

Oct 14, 2025

Can TransCode Therapeutics Inc. stock weather global recessionJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com

Oct 14, 2025

Oct 14, 2025

TransCode reports positive safety data from TTX-MC138 phase 1a trial - Investing.com Australia

Oct 14, 2025

Oct 14, 2025

TransCode reports positive safety data from TTX-MC138 phase 1a trial By Investing.com - Investing.com South Africa

Oct 14, 2025

Oct 14, 2025

Transcode Therapeutics’ TTX-MC138 achieves safety endpoint in Phase 1a study - TipRanks

Oct 14, 2025

Oct 14, 2025

Transcode Therapeutics completes phase 1a trial with TTX-MC138 in metastatic disease at ESMOSEC filing - MarketScreener

Oct 14, 2025

Oct 14, 2025

TransCode Therapeutics, Inc. Completes Phase 1a Clinical Trial with TTX-MC138 - TradingView

Oct 14, 2025

Oct 14, 2025

TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO - WV News

Oct 14, 2025

Oct 14, 2025

How to manage a losing position in TransCode Therapeutics Inc.July 2025 Rallies & Short-Term High Return Strategies - newser.com

Oct 14, 2025

Oct 14, 2025

Why TransCode Therapeutics Inc. stock is considered a top pick2025 Trading Recap & Risk Controlled Swing Alerts - newser.com

Oct 14, 2025

Oct 14, 2025

Is TransCode Therapeutics Inc. trending in predictive chart modelsJuly 2025 Decliners & Community Consensus Picks - newser.com

Oct 14, 2025

Oct 13, 2025

Exit strategy if you’re trapped in TransCode Therapeutics Inc.July 2025 Gainers & Real-Time Buy Zone Alerts - newser.com

Oct 13, 2025

Oct 13, 2025

Is a relief rally coming for TransCode Therapeutics Inc. holdersJuly 2025 Reactions & Daily Profit Focused Screening - newser.com

Oct 13, 2025

Oct 13, 2025

Using Bollinger Bands to evaluate TransCode Therapeutics Inc.2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - newser.com

Oct 13, 2025

Oct 13, 2025

Does TransCode Therapeutics Inc. qualify in momentum factor screeningBuy Signal & Weekly Setup with ROI Potential - newser.com

Oct 13, 2025

Oct 13, 2025

Heatmap analysis for TransCode Therapeutics Inc. and competitors2025 Market Sentiment & Free Safe Capital Growth Stock Tips - newser.com

Oct 13, 2025

Oct 13, 2025

Is TransCode Therapeutics Inc. stock poised for growthEarnings Summary Report & Verified High Yield Trade Plans - newser.com

Oct 13, 2025

Oct 13, 2025

CK Life unit merges with TransCode as Li Ka-shing firm eyes anticancer drugs - The Star

Oct 13, 2025

Oct 13, 2025

Is TransCode Therapeutics Inc. stock oversold or undervaluedMarket Growth Summary & AI Driven Stock Movement Reports - newser.com

Oct 13, 2025

Oct 09, 2025

Does TransCode Therapeutics Inc. fit your quant trading modelJuly 2025 WrapUp & Accurate Trade Setup Notifications - newser.com

Oct 09, 2025

Oct 09, 2025

CK Life Merges Polynoma with TransCode in $125M DealNews and Statistics - IndexBox

Oct 09, 2025

Oct 09, 2025

CK Life Sciences sees low geopolitical risks in a US merger - The Standard (HK)

Oct 09, 2025

Oct 09, 2025

Multi asset correlation models including TransCode Therapeutics Inc.July 2025 Highlights & Risk Managed Investment Strategies - newser.com

Oct 09, 2025

Oct 09, 2025

TransCode Therapeutics (NASDAQ:RNAZ) Earns “Sell (E+)” Rating from Weiss Ratings - Defense World

Oct 09, 2025

Oct 09, 2025

Critical Analysis: Century Therapeutics (NASDAQ:IPSC) and TransCode Therapeutics (NASDAQ:RNAZ) - Defense World

Oct 09, 2025

Oct 09, 2025

CKLIFE SCIENCES Estimates Completion of TransCode Preferred Stock Conversion in 6 Mths at Earliest - AASTOCKS.com

Oct 09, 2025

Oct 09, 2025

How hedge fund analytics apply to TransCode Therapeutics Inc. stockJuly 2025 Decliners & Advanced Technical Signal Analysis - newser.com

Oct 09, 2025

Oct 08, 2025

TransCode Therapeutics Acquires Polynoma, Secures $25 Million Investment to Advance Oncology Pipeline - citybuzz

Oct 08, 2025

Oct 08, 2025

TransCode Therapeutics, Inc. (RNAZ) Stock :Soars as $25M Investment and Polynoma Acquisition Ignite Growth Prospects - parameter.io

Oct 08, 2025

Oct 08, 2025

TransCode Therapeutics To Acquire Polynoma; $25M Financing By a Subsidiary Of CK Life Sciences - citybiz

Oct 08, 2025

Oct 08, 2025

TransCode Therapeutics to Acquire Polynoma, Receive Investment from CK Life Sciences - MarketScreener

Oct 08, 2025

Oct 08, 2025

TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout - Sahm

Oct 08, 2025

Oct 08, 2025

TransCode Therapeutics To Acquire Polynoma, Receive $25M Investment To Advance Key Asset - Stocktwits

Oct 08, 2025

Oct 08, 2025

Transcode announces the acquisition of Polynoma and a $25 mln financing by subsidiary of CK Life Sciences - MarketScreener

Oct 08, 2025

Oct 08, 2025

TransCode Therapeutics stock soars after Polynoma acquisition By Investing.com - Investing.com Canada

Oct 08, 2025

Oct 08, 2025

TransCode Acquires Polynoma, Secures $25M Strategic Investment | RNAZ Stock News - Stock Titan

Oct 08, 2025

Oct 08, 2025

Transcode Therapeutics To Acquire Polynoma, Receive $25M Investment To Advance Key Asset - Menafn.com

Oct 08, 2025

Oct 05, 2025

Chart based exit strategy for TransCode Therapeutics Inc.2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Strategies to average down on TransCode Therapeutics Inc.2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - newser.com

Oct 05, 2025

Oct 03, 2025

TransCode Therapeutics Amends Patent License Agreement - TipRanks

Oct 03, 2025

Oct 03, 2025

TransCode Therapeutics (NASDAQ:RNAZ) Trading Down 1.5% – What’s Next? - Defense World

Oct 03, 2025

Oct 03, 2025

Will TransCode Therapeutics Inc. stock go up soonMarket Activity Report & Growth Oriented Trade Recommendations - newser.com

Oct 03, 2025

Sep 30, 2025

Is TransCode Therapeutics Inc. stock bottoming outJuly 2025 Big Picture & Real-Time Volume Analysis Alerts - newser.com

Sep 30, 2025

Sep 29, 2025

TransCode Therapeutics Passes Key Proposals at Annual Meeting - MSN

Sep 29, 2025